Table 1 Inhibitors with higher selective Drug Sensitivity Scores (sDSS) for p60AmotL2-expressing cells compared to controls. This table highlights inhibitors that demonstrated higher sDSS for p60AmotL2-expressing cells in the validation screen, indicating drugs that selectively inhibit p60AmotL2-expressing cells compared to control cells. The sDSS was calculated by subtracting the Drug Sensitivity Score (DSS) value for control cells from the DSS value of p60AmotL2-expressing cells for each compound. sDSS values for both the primary screen and the validation screen for all 60 hit compounds are available in Supplemental Data 4

From: A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells